Inhaler Cipla
- All
- News
- Videos
-
Cipla Recalls 6 Batches Of Bronchospasm Treatment Inhalation Aerosol In US
Pharmaceutical firm Cipla Ltd on Friday said it is voluntarily recalling six batches of Albuterol Sulfate inhalation aerosol in the US market due to container defect.
-
Cipla Expects to Double Respiratory Drug Sales by 2020
Cipla Ltd, India's fourth-largest drug maker by revenue, expects sales from its respiratory drug portfolio to more than double by 2020 and remains on track to launch a keenly awaited inhaler in Britain, its chief executive said.
-
Cipla Shares Fall as Mylan Launches Asthma Inhaler in UK
Mylan launched generic MDI combination inhaler. The product is deemed bioequivalent to GSK's Seretide inhaler and this is the first generic version of GSK's Seretide Evohaler in UK.
-
Cipla Soars Over 8% on Launch of Anti-Asthma Inhaler
The inhaler will be sold under the Serroflo brand in Germany. In Sweden, it will be marketed as Salmeterol/Fluticasone Cipla, the company said in a statement.
-
Cipla Recalls 6 Batches Of Bronchospasm Treatment Inhalation Aerosol In US
Pharmaceutical firm Cipla Ltd on Friday said it is voluntarily recalling six batches of Albuterol Sulfate inhalation aerosol in the US market due to container defect.
-
Cipla Expects to Double Respiratory Drug Sales by 2020
Cipla Ltd, India's fourth-largest drug maker by revenue, expects sales from its respiratory drug portfolio to more than double by 2020 and remains on track to launch a keenly awaited inhaler in Britain, its chief executive said.
-
Cipla Shares Fall as Mylan Launches Asthma Inhaler in UK
Mylan launched generic MDI combination inhaler. The product is deemed bioequivalent to GSK's Seretide inhaler and this is the first generic version of GSK's Seretide Evohaler in UK.
-
Cipla Soars Over 8% on Launch of Anti-Asthma Inhaler
The inhaler will be sold under the Serroflo brand in Germany. In Sweden, it will be marketed as Salmeterol/Fluticasone Cipla, the company said in a statement.
